NSF award 2625332 · Gordon Research Conferences

Participant Support for Gordon Research Seminar & Gordon Research Conf on Signal Transduction in Engineered Extracellular Matrices; Les Diablerets, Switzerland; 30 May-5 June 2026

Final report due

28 February 2027

in 133 days · The award ends on 31 October 2026.

GrantClerk is a private service. We are not NSF or any government agency.

Dates this award owes

NSF emails you about this too.

No-cost extension notice21 Oct 2026in 3 days
award ending 2026-10-31 · Research.gov
PAPPG 24-1: “at least ten calendar days prior to the end date”
Final report due28 Feb 2027in 133 days
award ending 2026-10-31 · Research.gov
PAPPG 24-1: “no later than 120-days following the end date of the award”
Project outcomes report due28 Feb 2027in 133 days
award ending 2026-10-31 · Research.gov
PAPPG 24-1: “no later than 120 days following the end date”
Award is closed out28 Feb 2027in 133 days
award ending 2026-10-31 · Research.gov
PAPPG 24-1: “financially closed out 120 days after their expiration date”

Annual report dates come from the budget period on your award notice. That date is not public, so it is not shown here.

How we got this date

NSF lists this award's end date as 31 October 2026.
NSF rules say the final report is due no later than 120 days after that.
So the final report is due by 28 February 2027.

Read the rule on Research.gov

Get a note before each report date

Add this award to your desk. We email you before each date and keep the dates in one place.

Renews each year until you cancel. Cancel any time from your account.

Already a member? Sign in

Award card

Award number: 2625332
Period of support: 1 May 2026 – 31 Oct 2026
Amount: $10,000
Awardee: Gordon Research Conferences, East Greenwich, RI
Program: Engineering of Biomed Systems, BMMB-Biomech & Mechanobiology
Directorate: ENG

Abstract

The extracellular matrix (ECM) is the dynamic biological scaffolding that surrounds cells in every tissue and organ of the human body. Far from a passive support, the ECM actively directs cell growth, repair, and specialization. Disruption of these processes can lead to cancer, cardiac and pulmonary fibrosis, reproductive disease, and other conditions affecting millions of Americans. Engineering the ECM offers…

Is this right?

We copy this from the public NSF award record. Your award notice and NSF always win. If a date looks wrong, check Research.gov.